Conference Program 

ADIT 2018 Program planners and contributors:

Prof. Geremia B. Bolli, Dr. Matthew D. Campbell, Prof. Andrej Janez, Prof. Juris J. Meier, Prof. Lea Smircic Duvnjak, Prof. Hannele Yki Jarvinen

Sunday, April 15

11.30 - 12.00    Welcome Lunch

12.00 - 12.25   10th Anniversary: ADIT Opening I Lalic N., Metelko Z.

                            Opening Lecture I Janez A.

12.25 - 13.25   Diabetes and Cancer I Janez A.

                            Links between Cancer, Obesity, and Diabetes I Grunberger G.

                            Management of diabetes in patient with cancer I Chowdhury T.

13.25 - 13.30   Break

13.30 - 15.00  Diabetes and Heart I Yki Jarvinen H.

                           Diagnosis and treatment of heart disease in diabetes I Lotan C.

                           Treatment of thrombosis in patient with Diabetes & Case Q&A I Lassila R.

15.00 - 15.05  Break

15.05 - 16.05  CVOTs what did we learn so far? I Lalic N.

                           Endpoints of recent CVOTs I Schernthaner G.

                           CVOTs - Critical review I Meier J.J.

16.05 - 16.15  Break

16.15 - 17.15    Diabetes - liver - gut: connection that matters? I Taylor R.

                           Advanced fibrosis in patient with Diabetes I Yki Jarvinen H.

                           The Gut: A Key to the Pathogenesis of Type 2 Diabetes? I Knop F.K.

17.15 - 17.30   Coffee Break

17.30 - 19.00  Industry sponsored Session 

20.00- 22.00 Opening Ceremony & Reception

Monday, April 16

 8.00 -  9.00    Industry sponsored Session

  9.15 - 10.35   Optimization of Insulin therapy: Where to start? I Bolli G.

                         Overcoming Barriers to insulin therapy I Pouwer F.

                             T2DM: old tricks - new insulins or both I Yki Jarvinen H.

                             Insulin delivery methods: past present future I Kesavadev J.

10.35 - 10.45   Coffee Break

10.45 - 11.45    Injectable therapy in T2DM inadequately Controlled on Oral Agents: Fixed - dose or flexible combination? I Knop F.K.

                            Flexible dose combinations I Bolli G.
                            Fixed-dose combinatons I Standl E.

11.45 - 11.50    Break

11.50 - 12.20   ADIT 2018 Best Abstracts I Yki Jarvinen H.

                            Islet Autoantibodies Measurement and Genetic Testing I Pape Medvidovic E.

                            Long-term outcomes of bone-marrow mononuclear cell therapy, percutaneous angioplasty and conservative therapy in diabetic patients                                      with critical limb ischemia I Nemcova A.

                            Efficacy and safety of patient - versus physician-managed titration of insulin​ I Smircic Duvnjak L.

12.20 - 13.10   Lunch

13.10 - 14.10   Lifestyle modifications: reversal and prevention of T2DM I Mitrakou Fanariotou A.

                            Intensive LM for the prevention of T2DM I Campbell M.D.

                            Reversal of T2DM: An update of the DiRECT trial I Taylor R.

14.10 - 14.15    Break

14.15 - 15.45    Challenging patient Cases I Tesfaye S.

                            Obese patient with Type 2 diabetes and severe insulin resistance I Meier J.J.

                            Case: CKD in T1DM patient I Karalliedde J.

                            T2DM management in the elderly patient I Schernthaner G.

15.45 - 15.55   Break

15.55 - 17.15    ADIT Forum : Evidence based medicine: What is it and are we there yet? I Grunberger G.

                                                           I Bolli G.

                           Forum discussion​ I Bosnyak Z. 

                                                           I Standl E.                  

17.30 - 19.00   Industry sponsored Session

Tuesday, April 17

8.30 - 9.30      Microvascular complications: Retinopathy I Broz J., Veresiu I.

                            Plasticity of the Retinal Microvasculature I Tapp R.

                            Case presentation I Summanen P.

9.30  -  9.35    Break

9.35 - 10.35     How to balance efficacy and safety of new glucose lowering drugs? I Meier J.J.

                            SGLT2 I Smircic Duvnjak L.

                            Incretin based therapies (GLP-1 and DPP4) I Deacon C.F.

10.35 - 10.45   Coffee Break

10.45 - 11.45   Diabetic neuropathy and Diabetic foot I Standl S.

                            Treatment pathway for painful diabetic neuropathy I Tesfaye S.

                            Interactive case presentation: Diabetic ulcers I Meier J.J.

11.45 - 11.50    Break

11.50 - 12.50   T1DM: good to know I Bolli G.

                            Implications for Double Diabetes and CV Risk Reduction in T1DM I Campbell M.D.

                            Exercise and Physical Activity in Type 1 Diabetes I Yardley J.

13.00 - 13.45   Farewell Lunch